4358 related articles for article (PubMed ID: 6940183)
1. p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells.
Dippold WG; Jay G; DeLeo AB; Khoury G; Old LJ
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1695-9. PubMed ID: 6940183
[TBL] [Abstract][Full Text] [Related]
2. p53 transformation-related protein: detection of an associated phosphotransferase activity.
Jay G; Khoury G; DeLeo AB; Dippold WG; Old LJ
Proc Natl Acad Sci U S A; 1981 May; 78(5):2932-6. PubMed ID: 6265926
[TBL] [Abstract][Full Text] [Related]
3. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.
DeLeo AB; Jay G; Appella E; Dubois GC; Law LW; Old LJ
Proc Natl Acad Sci U S A; 1979 May; 76(5):2420-4. PubMed ID: 221923
[TBL] [Abstract][Full Text] [Related]
4. Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells.
Mercer WE; Nelson D; DeLeo AB; Old LJ; Baserga R
Proc Natl Acad Sci U S A; 1982 Oct; 79(20):6309-12. PubMed ID: 6292898
[TBL] [Abstract][Full Text] [Related]
5. P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts.
Rotter V; Abutbul H; Ben-Ze'ev A
EMBO J; 1983; 2(7):1041-7. PubMed ID: 6354706
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of the tumor suppressor/oncoprotein p53 in SV40 Tag-transformed human placental trophoblast and malignant trophoblast cell lines.
Aboagye-Mathiesen G; Zdravkovic M; Tóth FD; Graham CH; Lala PK; Ebbesen P
Early Pregnancy; 1996 Jun; 2(2):102-12. PubMed ID: 9363207
[TBL] [Abstract][Full Text] [Related]
7. The flexible evolutionary anchorage-dependent Pardee's restriction point of mammalian cells: how its deregulation may lead to cancer.
David-Pfeuty T
Biochim Biophys Acta; 2006 Jan; 1765(1):38-66. PubMed ID: 16219425
[TBL] [Abstract][Full Text] [Related]
8. Reversion to methionine independence in simian virus 40-transformed human and malignant rat fibroblasts is associated with altered ploidy and altered properties of transformation.
Hoffman RM; Jacobsen SJ; Erbe RW
Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1313-7. PubMed ID: 220612
[TBL] [Abstract][Full Text] [Related]
9. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
10. p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumor cells.
Rotter V
Proc Natl Acad Sci U S A; 1983 May; 80(9):2613-7. PubMed ID: 6189126
[TBL] [Abstract][Full Text] [Related]
11. A set of stage-dependent embryonic antigens expressed in cell cultures of BALB/c mouse embryos and in transformed cell lines.
Gerhards RE; Mehnert FE
J Cell Biochem; 1986; 31(1):27-39. PubMed ID: 3013908
[TBL] [Abstract][Full Text] [Related]
12. Altered chromosomal methylation patterns accompany oncogene-induced transformation of human bronchial epithelial cells.
Vertino PM; Spillare EA; Harris CC; Baylin SB
Cancer Res; 1993 Apr; 53(7):1684-9. PubMed ID: 8453642
[TBL] [Abstract][Full Text] [Related]
13. Comparison of fibrin clot retraction with other transformation parameters after hydridization of normal and established cell lines.
Curatolo L; Azzarone B; Fally-Crépin C; Morasca L; Macieira-Coelho A
Int J Cancer; 1983 Feb; 31(2):249-55. PubMed ID: 6681807
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression.
Deppert W; Buschhausen-Denker G; Patschinsky T; Steinmeyer K
Oncogene; 1990 Nov; 5(11):1701-6. PubMed ID: 2267136
[TBL] [Abstract][Full Text] [Related]
15. Wild type human p53 is antiproliferative in SV40-transformed hamster cells.
Mercer WE; Amin M; Sauve GJ; Appella E; Ullrich SJ; Romano JW
Oncogene; 1990 Jul; 5(7):973-80. PubMed ID: 2165234
[TBL] [Abstract][Full Text] [Related]
16. Variation in antigenic determinants of p53 transformation-related protein obtained from various species.
Rotter V; Friedman H; Katz A; Zerivitz K; Wolf D
J Immunol; 1983 Jul; 131(1):329-33. PubMed ID: 6190914
[TBL] [Abstract][Full Text] [Related]
17. Effect of decreased fte-1 gene expression on protein synthesis, cell growth, and transformation.
Kho CJ; Wang Y; Zarbl H
Cell Growth Differ; 1996 Sep; 7(9):1157-66. PubMed ID: 8877097
[TBL] [Abstract][Full Text] [Related]
18. Identification of transformation-related antigen by monoclonal antibody on Swiss 3T3 cells induced by transfection with murine cultured colon 36 tumor DNA.
Sato N; Sato T; Takahashi S; Okubo M; Yagihashi A; Koshiba H; Kikuchi K
J Natl Cancer Inst; 1987 Feb; 78(2):307-13. PubMed ID: 3468294
[TBL] [Abstract][Full Text] [Related]
19. Loss of normal G1 checkpoint control is an early step in carcinogenesis, independent of p53 status.
Syljuåsen RG; Krolewski B; Little JB
Cancer Res; 1999 Mar; 59(5):1008-14. PubMed ID: 10070956
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation.
Haynes BF; Hemler M; Cotner T; Mann DL; Eisenbarth GS; Strominger JL; Fauci AS
J Immunol; 1981 Jul; 127(1):347-51. PubMed ID: 6787129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
